In vitro assessment of chlorhexidine gluconate-impregnated polyurethane foam antimicrobial dressing using zone of inhibition assays

Infection Control and Hospital Epidemiology

Volumn 25, Issue 8, 2004, Pages 664-667

  Bhende, Shubhangi ^a   Spangler, Daniel ^a  

^a ETHICON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CHLORHEXIDINE GLUCONATE; POLYURETHAN FOAM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ASSAY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANDIDA ALBICANS; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEVICE INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND DRESSING; ZONE OF INHIBITION ASSAY;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CANDIDA ALBICANS; CHLORHEXIDINE; DRUG RESISTANCE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EQUIPMENT CONTAMINATION; MATERIALS TESTING; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; POLYURETHANES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 4143145178     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502458     Document Type: Article

References (24)

1. Malchesky P, Chamberlain V, Scott-Conner C, Salis B, Wallace C. Reprocessing of reusable medical devices. ASAIO J 1995;41:146-151.
2. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
3. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-1030.
4. Dimick JB, Pelz RK, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in a surgical intensive care unit. Arch Surg 2001;136:229-234.
5. Mermel LA. Catheter-related bloodstream infections [correction]. Ann Intern Med 2000;133:395.
6. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Bisno AL, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices, ed. 3. Washington, DC: ASM Press; 2000:173-209.
7. Campbell AA, Song L, Nelson BJ, et al. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 2000;53:400-407.
8. Moroni A, Vannini F, Mosca M, Giannini S. State of the art review: techniques to avoid pin loosening and infection in external fixation. J Orthop Trauma 2002;16:189-195.
9. Lewallen DG, Edwards CC. Complications of external fixation. In: Epps CH Jr, ed. Complications of Orthopedic Surgery, ed. 3. Philadelphia: J. B. Lippincott; 1994.
10. Pearson ML. Guideline for prevention of intravascular device-related infections. Infect Control Hosp Epidemiol 1996;17:438-473.
11. Sherertz RJ. Pathogenesis of vascular catheter infection. In: Bisno AL, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices, ed. 3. Washington, DC: ASM Press; 2000:111-125.
12. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991;91(suppl 3B):185S-191S.
13. Toltzis P, Goldmann DA. Current issues in central venous catheter infection. Ann Rev Med 1990;41:169-176.
14. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno AL, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices, ed. 2. Washington, DC: ASM Press; 1994:155-212.
15. Sherertz RJ. Pathogenesis of vascular catheter-related infections. In: Seifert H, Jansen B, Farr BM, eds. Catheter-Related Infections. New York: Marcel Dekker; 1997:1-30.
16. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520-532.
17. Maki DG, Narans LI, Kluger DM. Prospective randomized, investigator-masked trial of a novel chlorhexidine-impregnated disk (BIOPATCH) on central venous and arterial catheters. Infect Control Hosp Epidemiol 2000;21:96.
18. Maki DG. Preventing intravascular catheter-related infections: an evidence-based approach. Physician Weekly 2004;21. Available at www.physweekly.com/pc.asp?issuid=66&questionid=72. Accessed December 2003.
19. Banton J, Banning V. Impact of catheter-related bloodstream infections with the use of the BIOPATCH dressing. Journal of Vascular Access Devices 2002:27-32.
20. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: 1. Pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232-1242.
21. Bootman M, Yamamoto R, inventors; Integra LifeSciences I Ltd., assignee. Method of making a polyurethane-biopolymer composite. US patent 6,071,447. June 6, 2000.
22. Russell AD. Principles of antimicrobial activity and resistance. In: Block S, ed. Disinfection, Sterilization, and Preservation, ed. 5. Philadelphia: Lippincott Williams & Wilkins; 2001:47-49.
23. Russell AD. Bacterial sensitivity and resistance, plasmids and bacterial resistance. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and Practice of Disinfection, Preservation, and Sterilization, ed. 3. Oxford, England: Blackwell Science; 1999:299-301.
24. Stickler DJ, Thomas B. Antiseptic and antibiotic resistance in gram-negative bacteria causing urinary tract infection. J Clin Pathol 1980;33:288-296.